Hyundai Bioscience Co., Ltd.
KOE: 048410.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jong-Won Choi
- Employees
- 54
- Headquarters
- Seoul, South Korea
- IPO year
- 2002
- Market cap
- ₩1.3T
- Website
- https://www.hyundaibioscience.com
Loading 048410…
Loading profile data…Frequently asked questions about 048410
What does Hyundai Bioscience Co., Ltd. (048410.KQ) do?
Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system...
Where does 048410.KQ trade?
Hyundai Bioscience Co., Ltd. (048410.KQ) trades on the KOSDAQ.
What sector is 048410.KQ in?
Hyundai Bioscience Co., Ltd. (048410.KQ) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Hyundai Bioscience Co., Ltd.?
Jong-Won Choi is the chief executive officer of Hyundai Bioscience Co., Ltd. (048410.KQ).
Where is Hyundai Bioscience Co., Ltd. headquartered?
Hyundai Bioscience Co., Ltd. is headquartered in South Korea.
Does 048410.KQ pay a dividend?
Hyundai Bioscience Co., Ltd. (048410.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 048410.KQ go public?
Hyundai Bioscience Co., Ltd. (048410.KQ) completed its initial public offering in 2002.